Cargando…
Identification and validation of prognosis‐related DLX5 methylation as an epigenetic driver in myeloid neoplasms
The deregulated DLX gene family members DLX1/2/3/4/5/6 (DLXs) caused by DNA methylation has been demonstrated in various cancers with therapeutic target value. However, the potential role of DLXs methylation in myeloid neoplasms such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS...
Autores principales: | Zhang, Ting‐juan, Xu, Zi‐jun, Gu, Yu, Wen, Xiang‐mei, Ma, Ji‐chun, Zhang, Wei, Deng, Zhao‐qun, Leng, Jia‐yan, Qian, Jun, Lin, Jiang, Zhou, Jing‐dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403826/ https://www.ncbi.nlm.nih.gov/pubmed/32508046 http://dx.doi.org/10.1002/ctm2.29 |
Ejemplares similares
-
Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes
por: Zhou, Jing-dong, et al.
Publicado: (2020) -
DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis
por: Zhou, Jing-dong, et al.
Publicado: (2022) -
Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia
por: Zhang, Ting-juan, et al.
Publicado: (2021) -
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
por: Schwartz, Jason R., et al.
Publicado: (2021) -
Mutations in EZH2 are associated with poor prognosis for patients with myeloid neoplasms
por: Zhang, Qi, et al.
Publicado: (2019)